Meridian Bioscience, Inc. operates in the Diagnostic substances sector. Meridian Bioscience, Inc. (Meridian) is a fully-integrated life science company. The Company is engaged in the developing, manufacturing, selling and distribution of diagnostic test kits, for certain gastrointestinal, viral, respiratory and parasitic infectious diseases; the manufacture and distribution of bulk antigens, antibodies, polymerase chain reaction (PCR)/ quantitative polymerase chain reaction (qPCR) reagents, nucleotides, competent cells and bioresearch reagents used by researchers and other diagnostic manufacturers, and the contract development and manufacture of proteins and other biologicals under cyclic guanosine monophosphate (cGMP) conditions for use by biopharmaceutical and biotechnology companies engaged in research for new drugs and vaccines. The Company operates in three segments: U.S. Diagnostics, European Diagnostics and Life Science. On July 20, 2010, the Company completed the acquisition of the Bioline group of companies (collectively the Bioline Group). In our complete report available for purchase the company is compared to: Paragon Shipping Incorporation, Ultratech, Inc. and PMFG, Incorporation.